Search
Jun 7, 2023
Hopewell Therapeutics’ CEO on the company’s $25M raise and next-gen LNPs
Lou Brenner discusses his company’s raise today and explains how Hopewell is designing LNPs to go beyond the liver.
Also look for unique social pages for BiotechTV U.
At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.